PRINCIPAL FINANCIAL GROUP INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$281,231
-78.3%
33,640
-35.4%
0.00%
-100.0%
Q2 2023$1,293,641
+34.4%
52,079
-18.6%
0.00%0.0%
Q1 2023$962,200
+105.2%
63,976
+61.4%
0.00%
Q4 2022$468,823
+120.1%
39,630
+10.4%
0.00%
Q3 2022$213,000
+36.5%
35,908
-2.1%
0.00%
Q2 2022$156,000
-58.9%
36,693
-8.0%
0.00%
Q1 2022$380,000
-48.9%
39,897
+2.0%
0.00%
Q4 2021$743,000
-59.6%
39,121
-29.2%
0.00%
-100.0%
Q3 2021$1,840,000
-11.2%
55,284
+3.5%
0.00%0.0%
Q2 2021$2,072,000
-18.2%
53,424
+1.7%
0.00%
-50.0%
Q1 2021$2,533,000
-6.6%
52,547
+0.8%
0.00%0.0%
Q4 2020$2,713,000
+179.1%
52,152
+43.6%
0.00%
+100.0%
Q3 2020$972,000
+34.6%
36,322
-1.9%
0.00%0.0%
Q2 2020$722,000
+192.3%
37,031
+47.0%
0.00%
Q1 2020$247,000
-8.9%
25,191
+3.2%
0.00%
Q4 2019$271,000
+316.9%
24,401
+109.6%
0.00%
Q3 2019$65,000
+4.8%
11,641
+5.2%
0.00%
Q3 2018$62,00011,0630.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders